当前位置:循环首页>正文

[CIT2011]支架内血栓的处理——Ron Waksman教授现场专访

Management of In-Stent Restenosis——Live Interview with Dr. Ron Waksman

作者:  RonWaksman   日期:2011/3/22 15:40:03

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

Yes it is true that restenosis has been significantly reduced by the use of drug eluting stents but we still see about 5% of target lesion revascularization with simple lesions and with complex lesions we see them up to 10%. It is multi-factorial; there is not one single cause. For example, it could be mechanical as we have seen some stent fractures.

  International Circulation: The drug eluting stent was designed to attenuate the complication of in-stent restenosis but it didn’t eliminate this problem. What are the main reasons for in-stent restenosis after DES implantation?
  Dr. Waksman: Yes it is true that restenosis has been significantly reduced by the use of drug eluting stents but we still see about 5% of target lesion revascularization with simple lesions and with complex lesions we see them up to 10%. It is multi-factorial; there is not one single cause. For example, it could be mechanical as we have seen some stent fractures. When the stent fractures, the polymer also fractures and the drug is released and this, in itself, can induce restenosis, usually focal restenosis. There are some biological reasons. Sometimes the drug is not effective and that is also seen in oncology that not everyone is responsive to the drugs or there is some resistance to the drugs. We also see some inflammation from the polymer. Primarily in the first generation stents, we have seen that the polymer induces neointimal inflammation and this can lead to restenosis. We are also seeing recently very late restenosis which is basically complete healing which was initially delayed but there is a price to pay for that with very late restenosis. We have seen in some of the trials, a TLR rate of 24% up to 5 years. That is pretty high when you consider 25% restenosis rate is what we used to see after 6 months, but with the drug eluting stents we can see it at 4 or 5 years.

[1]  [2]  [3]  下一页

版面编辑:赵书芳  责任编辑:聂会珍



支架内再狭窄Ron Waksman药物洗脱支架PCIDES

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530